University Hospital Schleswig-holstein

This study is testing if starting treatment with a newer injectable biologic drug (mirikizumab) right away leads to better long-term disease control for people newly diagnosed with moderate-to-severe ulcerative colitis. It compares this 'top-down' approach to the current standard…

This study is observing how well an existing eczema medication called tralokinumab works for people whose moderate-to-severe eczema affects their genital area. Over 52 weeks, researchers will track 30 adult patients who are already starting this treatment as part of their regular…

This study aims to monitor the long-term heart and kidney health of women who experienced preeclampsia, HELLP syndrome, or kidney disease during pregnancy. It will follow 100 women to better understand their future health risks. The study is observational, meaning it collects hea…

This study aims to find early warning signs of Parkinson's disease in people who don't yet have symptoms. Researchers will screen 2,000 adults aged 50-99 who are at higher risk and follow them for five years to see who develops the disease. The goal is to understand how Parkinson…

This study is trying to understand why many people with Parkinson's disease crave sugary foods. Researchers will give 50 participants a sugary drink or a placebo drink on different days to see how it affects their blood sugar, insulin levels, and Parkinson's symptoms like movemen…